EIC Transition Challenge: Full scale Micro-Nano-Bio devices for medical and medical research applications
The EIC Transition Challenge supports the maturation and market exploitation of Micro-Nano-Bio technologies developed in previous EU-funded projects. This program aims to advance these innovative solutions from early technological readiness levels (TRL 3-4) to a market-ready stage, fostering European leadership in product innovation within the medical and medical research applications sector.
Who is Funded
This section details the eligible entities, geographical scope, and overarching objectives of the EIC Transition Challenge for Micro-Nano-Bio devices. It outlines specific criteria for applicants and the program's strategic goals in advancing innovative technologies to market.
What is Funded
This section outlines the types of projects, thematic areas, and developmental stages supported by the EIC Transition Challenge, focusing on its scope in advancing Micro-Nano-Bio devices for medical applications.
Type and Scope of Funding
This section details the financial support provided under the EIC Transition Challenge, including the type of financial instrument and the funding amounts available for projects.
Conditions and Requirements
This section outlines the general and specific conditions that applicants and beneficiaries must adhere to, covering aspects such as application criteria, consortium structures, and references to governing regulations.
Application Procedure
This section outlines the process for submitting applications and the subsequent evaluation and award procedures for the EIC Transition Challenge.
Legal Basis
This section identifies the foundational legal and official documents that govern the EIC Transition Challenge, ensuring its legitimacy and guiding its operational framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
2,500,000 €
Allocated Budget:
128,360,126 €
Award Channel:
Framework Programme Call
Region:
EU Member States and Associated Countries
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology
Application Type:
Optional Consortium
Funding Stages:
Experimental Development, Prototyping, Pilot Testing, Product Development, Market Introduction, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Website: